Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new tool for predicting erectile dysfunction.

D Day1, A Ambegaonkar, K Harriot

  • 1Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA.

Advances in Therapy
|September 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New Measurements of the Deuteron-to-Proton F_{2} Structure-Function Ratio.

Physical review letters·2025
Same author

Novel Measurement of the Neutron Magnetic Form Factor from A=3 Mirror Nuclei.

Physical review letters·2024
Same author

Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group.

ESMO open·2023
Same author

Revealing the short-range structure of the mirror nuclei <sup>3</sup>H and <sup>3</sup>He.

Nature·2022
Same author

Ruling out Color Transparency in Quasielastic ^{12}C(e,e^{'}p) up to Q^{2} of 14.2  (GeV/c)^{2}.

Physical review letters·2021
Same author

Probing the Deuteron at Very Large Internal Momenta.

Physical review letters·2021
Same journal

Treatment Patterns and Decision Drivers in Chinese Patients with Locally Advanced Cervical Cancer: Results from a National Physician Survey.

Advances in therapy·2026
Same journal

Matching-Adjusted Indirect Comparison of Tarlatamab for Patients with Platinum-Refractory or Platinum-Resistant Extensive-Stage Small-Cell Lung Cancer.

Advances in therapy·2026
Same journal

Sacral Neuromodulation for Refractory Overactive Bladder: Closing the Gaps in Anatomy, Mechanisms, and Parameter Selection.

Advances in therapy·2026
Same journal

Exploring the Impact of Delivering Allergy Medication as Self-Care on Healthcare Greenhouse Gas Emissions in the United Kingdom.

Advances in therapy·2026
Same journal

Management of Persistent Storage Symptoms and Overactive Bladder in Men Diagnosed with Benign Prostatic Hyperplasia: A Narrative Review.

Advances in therapy·2026
Same journal

Real-World Demographics, Clinical Characteristics, and Predictors of Persistence Among Males with Rett Syndrome Treated with Trofinetide.

Advances in therapy·2026
See all related articles

Physicians can now easily identify men at risk for erectile difficulty (ED) using a new computer-based Sexual Health Inventory for Men (SHIM) score indicator. This tool aids in early assessment and intervention for sexual health concerns.

Area of Science:

  • Urology
  • Men's Health
  • Medical Informatics

Background:

  • The Sexual Health Inventory for Men (SHIM) is effective for assessing erectile difficulty (ED).
  • Physician reluctance to use SHIM stems from its intimate nature.
  • A need exists for a discreet and efficient ED screening tool in clinical settings.

Purpose of the Study:

  • To develop and validate a user-friendly, computer-based SHIM score indicator for office use.
  • To facilitate early identification of men at high risk for ED.
  • To overcome barriers associated with traditional SHIM administration.

Main Methods:

  • Over 30,000 SHIM questionnaires were administered to men in physicians' offices.
  • Data included SHIM scores and patient demographics (age, smoking, diabetes, depression, hypertension, prostate disease, cholesterol).

Related Experiment Videos

  • A logistic regression model was developed to predict ED likelihood based on SHIM scores and clinical factors.

    • Main Results:

    • A logistic regression model achieved 81.8% sensitivity and 57.7% specificity in predicting ED (SHIM score < 21).
    • The model was integrated into a graphic, Windows-based computer program.
    • The SHIM score indicator provides rapid risk assessment for ED.

    Conclusions:

    • The computer-based SHIM score indicator is a convenient tool for physicians.
    • It effectively identifies patients requiring further ED assessment.
    • This technology can improve the integration of sexual health screening into routine practice.